Company · GSK (New York Stock Exchange)

GSK

Pharmaceutical Preparations

Key figures

Revenue, 2025: $43.69B
Employees: 99,300
Industry: Pharmaceutical Preparations (SIC 2834)
Institutional holders: 1,036 at 30 Jun 2026 (1,031 the quarter before)
SEC number: 1131399
LEI: 5493000HZTVUYLO1D793

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

GSK is a British multinational pharmaceutical and biotechnology company in pharmaceutical industry, headquartered in London, founded in 2000.

Source: Wikidata

Latest filings

21 Oct 2026

6-K US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B

19 Oct 2026

6-K JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER

19 Oct 2026

6-K RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER

15 Oct 2026

6-K DIRECTOR/PDMR SHAREHOLDING

14 Oct 2026

6-K DIRECTOR/PDMR SHAREHOLDING

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start free Sign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.